Hista-Aid References

  1. Greaves MW, Sabroe RA. Histamine: the quintessential mediator. J Dermatol. 1996 Nov;23(11):735-40
  2. Micek J, Jurkova T et al. Quercetin and its anti-allergic immune response. Molecules. 2016 May 12;21(5)
  3. Ueda H, Yamazaki C. Luteolin as an anti-inflammatory and anti-allergic constituent of Perilla frutescens. Biol Pharm Bull. 2002 Sep;25(9):1197-202
  4. Hagel AF, Layritz CM. Intravenous infusion of ascorbic acid decreases serum histamine concentrations in patients with allergic and non-allergic diseases. Naunyn Schmiedebergs Arch Pharmacol. 2013 Sep;386:789-793
  5. Vollbracht C, Rathel M. Intravenous vitamin C in the treatment of allergies: an interim subgroup analysis of a long-term observational study J Int Med Res. 2018 Sep;46(9):3640-3655
  6. Romero SA, Ely MR, Sieck DC, et al. Effect of antioxidants on histamine receptor activation and sustained postexercise vasodilatation in humans. Exp Physiol. 2015;100(4):435–449
  7. Jarisch R, Weyer D et al. Impact of oral victamin C on histamine levels and seasickness. J Vestib Res. 2014;24(4):281-8
  8. Rajora S, Suriano R. et al. 3,30 -Diindolylmethane modulates estrogen metabolism in patients with thyroid proliferative disease: a pilot study. Thyroid 2011(21):3; 299-304
  9. Bonds RS, Midoro-Horiuti T. Estrogen effects in allergy and asthma. Curr Opin Allergy Clin Immunol. 2013;13(1):92–99
  10. Zierau O, Zenclussen AC et al. Role of female sex hormones, estradiol and progesterone, in mast cell behavior. Front Immunol. 2012;3:169
  11. Bódis J1, Tinneberg HR et al. The effect of histamine on progesterone and estradiol secretion of human granulosa cells in serum-free culture. Gynecol Endocrinol. 1993 Dec;7(4):235-9
  12. Pawanker R, Canonica GW et al. White Book on Allergy 2011-2012 Executive Summary. World Health Organizatio Asthma and Allergy Foundation of America. Allergies. http://www.aafa.org/page/allergies.aspx September 2015. AAFA Web site. Accessed June 24, 2019
  13. Gupta RS, Warren CM et al. Prevalence and severity of food allergies among US adults. JAMA Netw Open. 2019 Jan 4;2(1):e18563
  14. Simons FE, Simons KJ. H1 antihistamines: current status and future circadians. World Allergy Organ J. 2008 Sep;1(9):145-55
  15. Branco AC, Yoshikawa FS et al. Role of histamine in modulating the immune response and inflammation. Mediators Inflamm. 2018: Aug 27;2018:9524075
  16. Fersti R, Akdis C et al. Histamine regulation of innate and adaptive immunity Front Biosci (Landmark Ed). 2012 Jan 1;17:40-53
  17. Benarroch EE. Histamine in the CNS: multiple functions and potential neurologic implications. Neurology. 2010 Oct 19;75(16):1472-9
  18. Vasoactive Amines. Available at: https://vet.uga.edu/ivcvm/courses/VPAT5200/03_inflammation/04_cmi/cmim02.htm (Accessed June 23, 2019)
  19. Parsons ME, Ganellin CR. Histamine and its receptors. Br J Pharmacol. 2006;147 Suppl 1(Suppl 1):S127–S135
  20. Krystel-Whittemore M, Dileepan KN et al. Mast Cell: a multi-functional master cell. Immunol. 2016;6:620
  21. Pinzer TC, Tietz E et al. Circadian profiling reveals higher histamine plasma levels and lower diamine oxidase serum activities in 24% of patients with suspected histamine intolerance compared to food allergy and controls Allergy. 2018 Apr; 73(4): 949–957
  22. Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr. 2007 May;85(5):1185-96
  23. Frieri M, Patel R et al. Mast cell activation syndrome: a review. Curr Allergy Asthma Rep. 2013 Feb;13(1):27-32
  24. Cingi C, Gevaert P et al. Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report. Clin Transl Allergy. 2017;7:17
  25. Gough H, Grabenhenrich L et al. Allergic multimorbidity of asthma, rhinitis and eczema over 20 years in the German birth cohort MAS. Pediatr Allergy Immunol. 2015;26(5):431–437
  26. Amellal M, Bronner C et al. Inhibition of mast cell histamine release by flavonoids and biflavonoids.Planta Med. 1985 Feb;51(1):16-20
  27. Karuppagounder V, Arumugam S. Molecular targets of quercetin with anti-inflammatory properties in atopic dermatitis. Drug Discov Today. 2016 Apr;21(4):632-9
  28. Kimata M, Inagaki N et al. Effects of luteolin and other flavonoids on IgE-mediated allergic reactions. Planta Med. 2000 Feb;66(1):25-9
  29. Kempuraj D, Tagen M et al. Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell dependent stimulation of Jurkat T cells. Br J Pharmacol 2008;155: 1076–84.
  30. Kimata M, Shichijo et al. Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clin Exp Allergy 2000;30:501–8.
  31. Seelinger G, Merfort I et al. Anti-oxidant, anti-inflammatory and antiallergic activities of luteolin. Planta Med. 2008: 74, 1667–1677.
  32. Bendich A. The antioxidant role of vitamin C. Adv Free Radic Biol Med. 1986 Dec;2(2):419-44
  33. Meister A. Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem. 1994 Apr 1;269(13):9397-400
  34. Vollbracht C, Raithel M et al. Intravenous vitamin C in the treatment of allergies: an interim subgroupanalysis of a long-term observational study J Int Med Res. 2018 Sep;46(9):3640-3655
  35. Jiang L, Diaz PT et al. Molecular characterization of redox mechanisms in allergic asthma. Ann Allergy Asthma Immunol 2014; 113: 137–142.
  36. Fogarty A, Lewis SA et al. Corticosteroid sparing effects of vitamin C and magnesium in asthma: a randomized trial. Respir Med 2006; 100: Immunol 2014; 113: 137–142.
  37. Hagel AF, Layritz CM et al. Intravenous infusion of ascorbic acid decreases serum histamine concentrations in patients with allergic and non-allergic diseases. Naunyn Schmiedebergs Arch Pharmacol 2013; 386: 789–793
  38. Johnston CS. The antihistamine action of ascorbic acid. Subcell Biochem 1996;25:189 –213.
  39. Ye J, Piao H et al. Polydatin inhibits mast cell-mediated allergic inflammation by targeting PI3K/Akt, MAPK, NF-κB and Nrf2/HO-1 pathways. Sci Rep. 2017 Sep 19;7(1):11895
  40. Papp D, Lenti K et al. The NRF2-related interactome and regulome contain multifunctional proteins and fine-tuned autoregulatory loops, FEBS Lett. 586 (2016) 1795–1802.
  41. Ernst IM, Schuemann C et al. 3,3′-Diindolylmethane but not indole-3-carbinol activates Nrf2 and induces Nrf2 target gene expression in cultured murine fibroblasts. Free Radic Res. 2011 Aug;45(8):941-9.
  42. Anderton MJ, Manson MM et al. Physiological modeling of formulated and crystalline 3,3′-diindolylmethane pharmacokinetics following oral administration in mice. Drug Metab Dispos. 2004 Jun;32(6):632-8.
  43. Boyle RJ, Hardikar W et al. The development of food allergy after liver transplantation. Liver Transplant. 2005;11:326–30
  44. Spector AA, Yorek MA. Membrane lipid composition and cellular function. J Lipid Res. 1985 Sep;26(9):1015-35
  45. Chang CY, Ke DS. Essential fatty acids and human brain. Acta Neurol Taiwan. 2009 Dec;18(4):231-41
  46. Porter CJ. Drug delivery to the lymphatic system. Crit Rev Ther Drug Carrier Syst. 1997;14(4):333-93
  47. Ahn H, Park JH. Liposomal delivery systems for intestinal lymphatic drug transport. Biomater Res. 2016 Nov 23;20:36
  48. Alyautdin R, Khlain I et al. Nanoscale drug delivery systems and the blood brain barrier. Int J Nanomedicine. 2014 Feb 7;9:795-811